We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$79.7B
AUM Growth
+$3.42B
(+4.5%)
Cap. Flow
-$854M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
1,817
New
122
Increased
851
Reduced
711
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$281M |
| 2 |
Comcast
CMCSA
|
+$235M |
| 3 |
Apple
AAPL
|
+$172M |
| 4 |
MetLife
MET
|
+$151M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$399M |
| 2 |
UBS Group
UBS
|
+$393M |
| 3 |
Televisa
TV
|
+$305M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$278M |
| 5 |
New Oriental
EDU
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.42% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Technology | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KSU
1576
DELISTED
Kansas City Southern
KSU
| $239K | ﹤0.01% |
2,559
+335
| +15% | +$31.7K |
|
1577
Jack in the Box
JACK
$278M
| $238K | ﹤0.01% |
2,483
-234
| -9% | -$22.2K |
|
|
ALOG
1578
DELISTED
Analogic Corp
ALOG
| $238K | ﹤0.01% |
2,681
-301
| -10% | -$26.1K |
|
1579
First Majestic Silver
AG
$8.05B
| $237K | ﹤0.01% |
+23,000
| New | +$337K |
|
1580
First Bancorp
FBP
$4.4B
| $237K | ﹤0.01% |
45,503
-2,192
| -5% | -$10.1K |
|
1581
Helen of Troy
HELE
$663M
| $237K | ﹤0.01% |
2,756
+561
| +26% | +$52.6K |
|
1582
Illumina
ILMN
$29.4B
| $237K | ﹤0.01% |
+1,339
| New | +$214K |
|
1583
Murphy Oil
MUR
$5.58B
| $237K | ﹤0.01% |
7,806
-19,700
| -72% | -$562K |
|
1584
RE/MAX Holdings
RMAX
$200M
| $237K | ﹤0.01% |
5,410
-437
| -7% | -$18.5K |
|
1585
Revvity
RVTY
$12.3B
| $237K | ﹤0.01% |
+4,215
| New | +$230K |
|
1586
New York Times
NYT
$11.6B
| $236K | ﹤0.01% |
19,782
+138
| +0.7% | +$1.75K |
|
1587
United Therapeutics
UTHR
$26.3B
| $235K | ﹤0.01% |
1,986
+1
| +0.1% | +$120 |
|
|
HMSY
1588
DELISTED
HMS Holdings Corp.
HMSY
| $235K | ﹤0.01% |
10,584
-2,337
| -18% | -$49.1K |
|
|
RSTI
1589
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $235K | ﹤0.01% |
7,316
-23,712
| -76% | -$759K |
|
1590
LSB Industries
LXU
$881M
| $234K | ﹤0.01% |
35,420
+1,513
| +4% | +$12.9K |
|
|
AMRI
1591
DELISTED
Albany Molecular Research Inc
AMRI
| $234K | ﹤0.01% |
14,176
+476
| +3% | +$7.05K |
|
|
RHT
1592
DELISTED
Red Hat Inc
RHT
| $234K | ﹤0.01% |
2,900
-215,310
| -99% | -$16M |
|
1593
Akamai
AKAM
$16.8B
| $233K | ﹤0.01% |
4,403
+770
| +21% | +$41.2K |
|
1594
Interparfums
IPAR
$3.92B
| $233K | ﹤0.01% |
7,232
-200
| -3% | -$6.4K |
|
1595
Viasat
VSAT
$9.79B
| $233K | ﹤0.01% |
3,117
+175
| +6% | +$13K |
|
1596
Marcus Corp
MCS
$732M
| $232K | ﹤0.01% |
9,283
-1,499
| -14% | -$34.3K |
|
|
PRFT
1597
DELISTED
Perficient Inc
PRFT
| $232K | ﹤0.01% |
11,516
+898
| +8% | +$18.5K |
|
|
CLC
1598
DELISTED
Clarcor
CLC
| $232K | ﹤0.01% |
3,564
-35
| -1% | -$2.21K |
|
1599
Banner Corp
BANR
$2.39B
| $231K | ﹤0.01% |
5,271
+406
| +8% | +$17.5K |
|
|
ETFC
1600
DELISTED
E*Trade Financial Corporation
ETFC
| $230K | ﹤0.01% |
7,909
-798
| -9% | -$20.6K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2016 Portfolio in Review
As of Q3 2016, OppenheimerFunds held 1,817 positions worth $79.7B, up 4.5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q3 2016 filing shows 122 new, 851 increased, 711 reduced and 96 closed positions. Its largest new stake was Fomento Económico Mexicano: 1,462,419 shares worth $135M. The largest sale was Bristol-Myers Squibb, an estimated $399M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q3 2016 buy was Fomento Económico Mexicano: 1,462,419 shares worth $135M.
- OppenheimerFunds added most to Johnson Controls International in Q3 2016, an estimated $281M increase.
- OppenheimerFunds's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $399M.
- OppenheimerFunds fully exited UBS Group in Q3 2016, selling an estimated $393M.
- OppenheimerFunds's ten largest holdings make up 14% of its $79.7B portfolio in Q3 2016.
- OppenheimerFunds opened 122 new positions and closed 96 in Q3 2016.
- OppenheimerFunds's portfolio value rose 4.5% quarter-over-quarter to $79.7B.
Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.